Filing Flows › Globus Medical (GMED) › Q2 2026 › vs Q2 2025
Globus Medical (GMED) Q2 2026 vs Q2 2025 (year over year)
Globus Medical's revenue rose $44.3M (+6%) from $745M in Q2 2025 to $790M in Q2 2026. The biggest changes: Musculoskeletal Solutions +$53.4M (+8%); Enabling Technologies −$9.1M (-26%). Operating margin 23.1% against 10.2% (+12.9 pts).
Globus Medical, Q2 2026: revenue $790M (+6% year over year), operating margin 23.1%, net earnings $152M, operating cash flow $210M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 23.1% | 10.2% | +12.9 pts |
| Net margin | 19.2% | 27.2% | -8.0 pts |
| Free cash flow margin | 22.4% | 4.2% | +18.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Musculoskeletal Solutions | $764M | $710M | $53.4M | +8% |
| Enabling Technologies | $26.1M | $35.2M | −$9.1M | -26% |
| Revenue | $790M | $745M | $44.3M | +6% |
| Other income, net | $7.4M | $112M | −$105M | -93% |
| Operating profit | $182M | $76.1M | $106M | +140% |
| Costs & expenses | $607M | $669M | −$62.1M | -9% |
| Pre-tax earnings | $190M | $188M | $1.6M | +0.9% |
| Cost of revenue | $241M | $249M | −$7.3M | -3% |
| Research & development | $36.3M | $40.0M | −$3.6M | -9% |
| SG&A | $287M | $304M | −$16.8M | -6% |
| Other operating costs | $42.6M | $76.9M | −$34.3M | -45% |
| Net earnings | $152M | $203M | −$51.3M | -25% |
| Income tax | $38.2M | −$14.7M | $52.9M | — |
| Depreciation & amortization | $69.5M | $70.6M | −$1.1M | -2% |
| Share-based compensation | $13.4M | $13.6M | −$234K | -2% |
| Working capital & other | $24.7M | $209M | −$185M | -88% |
| Operating cash flow | $210M | $77.9M | $132M | +169% |
| Free cash flow (company-reported) | $177M | $31.3M | $145M | +464% |
| Purchases of property and equipment | $33.2M | $46.6M | −$13.4M | -29% |
Questions
How much did Globus Medical's revenue grow year over year in Q2 2026?
Globus Medical's revenue rose $44.3M (+6%) from $745M in Q2 2025 to $790M in Q2 2026.
What drove Globus Medical's revenue change in Q2 2026?
Musculoskeletal Solutions +$53.4M (+8%); Enabling Technologies −$9.1M (-26%).